Expression of Matrix Metalloproteinase-7 is an Unfavorable Prognostic Factor in Intrahepatic Cholangiocarcinoma

Development of molecularly targeted therapies in biliary tract cancers: Reassessing the challenges and opportunities

(2011) Andrew X. Zhu et al.   HEPATOLOGY

Prognostic Value of Cirrhosis for Intrahepatic Cholangiocarcinoma After Surgical Treatment

(2011) Ya-yong Li et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Prognostic Factors After Surgical Resection for Intrahepatic, Hilar, and Distal Cholangiocarcinoma

(2010) Yoshiaki Murakami et al.   ANNALS OF SURGICAL ONCOLOGY

Matrix Metalloproteinase-9 Functions as a Tumor Suppressor in Colitis-Associated Cancer

(2010) P. Garg et al.   CANCER RESEARCH

Clinicopathologic and Treatment-Related Factors Influencing Recurrence and Survival after Hepatic Resection of Intrahepatic Cholangiocarcinoma: A 19-Year Experience from an Established Australian Hepatobiliary Unit

(2010) Akshat Saxena et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study

(2010) Birgit Gruenberger et al.   LANCET ONCOLOGY

Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer

(2010) Juan Valle et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prospective study of MMP7 serum levels in the diagnosis of cholangiocarcinoma

(2010) Kawin Leelawat   WORLD JOURNAL OF GASTROENTEROLOGY

Detection of serum MMP-7 and MMP-9 in cholangiocarcinoma patients: evaluation of diagnostic accuracy

(2009) Kawin Leelawat et al.   BMC GASTROENTEROLOGY

A phase II study of lapatinib in patients with advanced biliary tree and hepatocellular cancer

(2009) Ramesh K. Ramanathan et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study

(2009) Andrew X Zhu et al.   LANCET ONCOLOGY

Expression of Matrix Metalloproteinase 2 and Extracellular Matrix Metalloproteinase Inducer are Unfavorable Postoperative Prognostic Factors in Intrahepatic Cholangiocarcinoma

(2009) Che Zhang et al.   PATHOLOGY & ONCOLOGY RESEARCH

Cholangiocarcinoma

(2008) Boris R.A. Blechacz et al.   Clinics in Liver Disease

Cholangiocarcinoma: Advances in pathogenesis, diagnosis, and treatment

(2008) Boris Blechacz et al.   HEPATOLOGY

Expression of matrix metalloproteinase 7 is an unfavorable postoperative prognostic factor in cholangiocarcinoma of the perihilar, hilar, and extrahepatic bile ducts

(2008) Keita Itatsu et al.   HUMAN PATHOLOGY